These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9795392)

  • 21. Differential immune responses to staphylococcal enterotoxin B mutations in a hydrophobic loop dominating the interface with major histocompatibility complex class II receptors.
    Woody MA; Krakauer T; Ulrich RG; Stiles BG
    J Infect Dis; 1998 Apr; 177(4):1013-22. PubMed ID: 9534976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intranasal exposure to bacterial superantigens induces airway inflammation in HLA class II transgenic mice.
    Rajagopalan G; Iijima K; Singh M; Kita H; Patel R; David CS
    Infect Immun; 2006 Feb; 74(2):1284-96. PubMed ID: 16428778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial superantigens in human disease: structure, function and diversity.
    Ulrich RG; Bavari S; Olson MA
    Trends Microbiol; 1995 Dec; 3(12):463-8. PubMed ID: 8800837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-reactive antibodies prevent the lethal effects of Staphylococcus aureus superantigens.
    Bavari S; Ulrich RG; LeClaire RD
    J Infect Dis; 1999 Oct; 180(4):1365-9. PubMed ID: 10479174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered orientation of streptococcal superantigen (SSA) on HLA-DR1 allows unconventional regions to contribute to SSA Vbeta specificity.
    Stevens KR; Van M; Lamphear JG; Rich RR
    J Immunol; 1996 Dec; 157(11):4970-8. PubMed ID: 8943403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunization with glutathione S-transferase and mutant toxic shock syndrome toxin 1 fusion protein protects against Staphylococcus aureus infection.
    Cui JC; Hu DL; Lin YC; Qian AD; Nakane A
    FEMS Immunol Med Microbiol; 2005 Jul; 45(1):45-51. PubMed ID: 15985222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Superantigens: structure and relevance to human disease.
    Johnson HM; Torres BA; Soos JM
    Proc Soc Exp Biol Med; 1996 Jun; 212(2):99-109. PubMed ID: 8650257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Staphylococcal enterotoxin A has two cooperative binding sites on major histocompatibility complex class II.
    Hudson KR; Tiedemann RE; Urban RG; Lowe SC; Strominger JL; Fraser JD
    J Exp Med; 1995 Sep; 182(3):711-20. PubMed ID: 7650479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide antagonists of superantigen toxins.
    Kaempfer R
    Mol Divers; 2004; 8(2):113-20. PubMed ID: 15209162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal structure of a superantigen bound to MHC class II displays zinc and peptide dependence.
    Petersson K; Håkansson M; Nilsson H; Forsberg G; Svensson LA; Liljas A; Walse B
    EMBO J; 2001 Jul; 20(13):3306-12. PubMed ID: 11432818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1.
    Acharya KR; Passalacqua EF; Jones EY; Harlos K; Stuart DI; Brehm RD; Tranter HS
    Nature; 1994 Jan; 367(6458):94-7. PubMed ID: 8107781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defining a novel domain of staphylococcal toxic shock syndrome toxin-1 critical for major histocompatibility complex class II binding, superantigenic activity, and lethality.
    Kum WW; Laupland KB; Chow AW
    Can J Microbiol; 2000 Feb; 46(2):171-9. PubMed ID: 10721486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Staphylococcal and streptococcal superantigens: molecular, biological and clinical aspects.
    Alouf JE; Müller-Alouf H
    Int J Med Microbiol; 2003 Feb; 292(7-8):429-40. PubMed ID: 12635926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural basis for abrogated binding between staphylococcal enterotoxin A superantigen vaccine and MHC-IIalpha.
    Krupka HI; Segelke BW; Ulrich RG; Ringhofer S; Knapp M; Rupp B
    Protein Sci; 2002 Mar; 11(3):642-51. PubMed ID: 11847286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Superantigen natural affinity maturation revealed by the crystal structure of staphylococcal enterotoxin G and its binding to T-cell receptor Vbeta8.2.
    Fernández MM; Bhattacharya S; De Marzi MC; Brown PH; Kerzic M; Schuck P; Mariuzza RA; Malchiodi EL
    Proteins; 2007 Jul; 68(1):389-402. PubMed ID: 17427250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1.
    Kum WW; Chow AW
    J Infect Dis; 2001 Jun; 183(12):1739-48. PubMed ID: 11372026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Humanlike immune response of human leukocyte antigen-DR3 transgenic mice to staphylococcal enterotoxins: a novel model for superantigen vaccines.
    DaSilva L; Welcher BC; Ulrich RG; Aman MJ; David CS; Bavari S
    J Infect Dis; 2002 Jun; 185(12):1754-60. PubMed ID: 12085321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The refined crystal structure of toxic shock syndrome toxin-1 at 2.07 A resolution.
    Papageorgiou AC; Brehm RD; Leonidas DD; Tranter HS; Acharya KR
    J Mol Biol; 1996 Jul; 260(4):553-69. PubMed ID: 8759320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subsets of HLA-DR1 molecules defined by SEB and TSST-1 binding.
    Thibodeau J; Cloutier I; Lavoie PM; Labrecque N; Mourad W; Jardetzky T; Sékaly RP
    Science; 1994 Dec; 266(5192):1874-8. PubMed ID: 7997881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular characterization of the putative T-cell receptor cavity of the superantigen staphylococcal enterotoxin B.
    Garcia C; Briggs C; Zhang L; Guan L; Gabriel JL; Rogers TJ
    Immunology; 1998 Jun; 94(2):160-6. PubMed ID: 9741336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.